<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T21:18:57Z</responseDate>
  <request identifier="oai:figshare.com:article/33771772" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33771772</identifier>
        <datestamp>2026-09-15T05:35:14Z</datestamp>
        <setSpec>category_450</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Data Sheet 1_Imaging-based development and validation of artificial intelligence models for lung adenocarcinoma precursor lesions and early lung adenocarcinoma presenting as pulmonary nodules.docx</dc:title>
          <dc:creator>Junbao Zhang (15406312)</dc:creator>
          <dc:creator>Yanyi Hou (24912580)</dc:creator>
          <dc:creator>Yikang Yang (24141972)</dc:creator>
          <dc:creator>Ziyan Zhang (800393)</dc:creator>
          <dc:creator>Yi Gao (112914)</dc:creator>
          <dc:creator>Ping Xu (122619)</dc:creator>
          <dc:subject>Knowledge Representation and Machine Learning</dc:subject>
          <dc:subject>DINOv3</dc:subject>
          <dc:subject>invasiveness prediction</dc:subject>
          <dc:subject>lung adenocarcinoma</dc:subject>
          <dc:subject>multimodal learning</dc:subject>
          <dc:subject>pulmonary nodules</dc:subject>
          <dc:description>Background&lt;p&gt;Accurate preoperative assessment of pulmonary nodule invasiveness remains challenging. We developed an internally validated multimodal framework integrating CT representations from a frozen vision foundation model with clinical variables.&lt;/p&gt;Methods&lt;p&gt;This retrospective single-centre study included 1,179 pathologically confirmed pulmonary nodules: 247 glandular precursor lesions comprising atypical adenomatous hyperplasia and adenocarcinoma in situ, and 932 invasive lesions comprising minimally invasive and invasive adenocarcinoma. CT volumes were resampled to 0.5-mm isotropic resolution and cropped into 64 × 64 × 64-voxel patches. Slice-level representations were extracted using a pretrained, frozen DINOv3 backbone and aggregated by a trainable Attention Probe. Encoded clinical variables and imaging representations were integrated through self-attention and bidirectional cross-attention, followed by neural classification and regression tree classification. Internal validation used a five-fold rotating train–validation–test procedure, with each fold serving once as the held-out test fold.&lt;/p&gt;Results&lt;p&gt;The held-out test-fold AUCs were 0.848, 0.864, 0.867, 0.882, and 0.822, yielding a mean AUC of 0.8566. Pooled out-of-fold predictions produced an AUC of 0.847, accuracy of 0.809, sensitivity of 0.806, specificity of 0.822, and F1 score of 0.873. DINOv3 and NCART achieved the highest point-estimate AUCs among the evaluated feature extractors and classifiers, respectively, although most pairwise differences were not statistically significant. Intermediate fusion significantly outperformed the Gould score and the clinical-data-only model, but not the imaging-only or late-fusion models. In the prespecified secondary analysis, the model achieved an AUC of 0.780 for distinguishing adenocarcinoma in situ from atypical adenomatous hyperplasia.&lt;/p&gt;Conclusion&lt;p&gt;The proposed framework achieved internally validated discrimination of pulmonary nodule invasiveness. External multicentre and prospective validation is required before clinical implementation.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-15T05:35:14Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/frai.2026.1889248.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Data_Sheet_1_Imaging-based_development_and_validation_of_artificial_intelligence_models_for_lung_adenocarcinoma_precursor_lesions_and_early_lung_adenocarcinoma_presenting_as_pulmonary_nodules_docx/33771772</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
